High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan

Publisher： Karger

E-ISSN： 1421-9662|135|3|156-161

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.3, 2015-11, pp. : 156-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PET2‐driven de‐escalation therapy in 64 high‐risk Hodgkin Lymphoma patients treated with escalated BEACOPP

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 278-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility and efficacy of dose‐dense and dose‐intense ABVD for high‐risk patients with advanced Hodgkin lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 4, 2015-11 ,pp. : 662-665

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk stratification in patients with advanced‐stage breast cancer by pretreatment [18F]FDG PET/CT

By  

CANCER, Vol. 121, Iss. 22, 2015-11 ,pp. : 3965-3974

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility and efficacy of dose‐dense and dose‐intense ABVD for high‐risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 4, 2015-11 ,pp. : 665-668

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of bone marrow biopsy and FDG‐PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non‐Hodgkin B‐cell lymphoma and Hodgkin lymphoma. accuracy in a multicenter series of 372 patients

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 686-690

John Wiley & Sons Inc

Access to resources Recommend Favorite